These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12801971

  • 1. Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.
    Rodinò S, Saccà N, D'Amico T, Fragomeni A, Giglio A.
    Gut; 2003 Jul; 52(7):1070. PubMed ID: 12801971
    [No Abstract] [Full Text] [Related]

  • 2. Review article: the efficacy of infliximab in Crohn's disease--healing of fistulae.
    Present DH.
    Aliment Pharmacol Ther; 1999 Sep; 13 Suppl 4():23-8; discussion 38. PubMed ID: 10597336
    [Abstract] [Full Text] [Related]

  • 3. Rapid response of severe refractory metastatic Crohn's disease to infliximab.
    Miller AM, Elliott PR, Fink R, Connell W.
    J Gastroenterol Hepatol; 2001 Aug; 16(8):940-2. PubMed ID: 11555113
    [Abstract] [Full Text] [Related]

  • 4. Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: comments from Spanish experience.
    González Lama Y, Abreu LE, Vera MI, de la Revilla J, Fernandez-Puga N, Escartin P.
    Gastroenterology; 2004 Mar; 126(3):942-3; author reply 943. PubMed ID: 14988864
    [No Abstract] [Full Text] [Related]

  • 5. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection.
    Campbell S, Ghosh S.
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):191-2. PubMed ID: 11246620
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment-resistant lingual Crohn's disease disappears after infliximab.
    Brunner B, Hirschi C, Weimann R, Seibold F.
    Scand J Gastroenterol; 2005 Oct; 40(10):1255-9. PubMed ID: 16265783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infliximab in the management of the extra-intestinal manifestations of Crohn's disease.
    Lawrance IC.
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1332-3. PubMed ID: 15482549
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F, Nagy F, Szepes Z, Kiss I, Lonovics J, Molnár T.
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract] [Full Text] [Related]

  • 13. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK, Han DS, Eun CS.
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract] [Full Text] [Related]

  • 14. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
    Gill KR, Mahadevan U.
    Inflamm Bowel Dis; 2005 Feb; 11(2):210-2. PubMed ID: 15677920
    [No Abstract] [Full Text] [Related]

  • 15. Infliximab as first-line therapy for severe Crohn's disease?
    Cohen RD.
    Inflamm Bowel Dis; 2002 Jan; 8(1):58-9; discussion 63-5. PubMed ID: 11837940
    [No Abstract] [Full Text] [Related]

  • 16. Closure of jejuno-colic fistula in Crohn's disease with infliximab.
    Sood A, Midha V, Sood N.
    Indian J Gastroenterol; 2001 Jan; 20(4):164-5. PubMed ID: 11497186
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Infliximab for severe peripheral ulcerative keratopathy revealing Crohn's disease.
    Angioi K, Kaminsky P, Peyrin-Biroulet L.
    Inflamm Bowel Dis; 2011 Mar; 17(3):866-7. PubMed ID: 20848541
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.